Adverse reaction reporting and new antipsychotics.
Kerwin
R
R
Institute of Psychiatry, London, UK.
D000380:Agranulocytosis / Q000139:chemically induced; D000741:Anemia, Aplastic / Q000139:chemically induced; D014150:Antipsychotic Agents / Q000009:adverse effects*; D003024:Clozapine / Q000009:adverse effects*; D016903:Drug Monitoring; D006801:Humans; D007555:Isoxazoles / Q000009:adverse effects*; D009503:Neutropenia / Q000139:chemically induced; D010880:Piperidines / Q000009:adverse effects*; D017330:Remoxipride / Q000009:adverse effects*; D018967:Risperidone; D012559:Schizophrenia / Q000188:drug therapy
D014150:Antipsychotic Agents; D007555:Isoxazoles; D010880:Piperidines; D017330:Remoxipride; D003024:Clozapine; D018967:Risperidone